News
Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after pharma giant ...
Hims & Hers Health partners with Novo Nordisk (NVO) to offer Wegovy, boosting weight-loss solutions. See why I remain ...
In essence, Hims & Hers is embracing a "if you can't beat 'em, join 'em" approach that gives their customers more options.
PEMBROKE PARK, Fla. – Drugmaker Novo Nordisk announced Tuesday that Wegovy will be available through telehealth providers.
Overall, though, we'd argue that HIMS's stock is in a great position to sell puts on. At this price, the options pay a ...
Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
Citi lowered the firm’s price target on Hims & Hers to $25 from $27 and keeps a Sell rating on the shares. The firm also added a “downside ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback